The central inquiry concerns the potential negative health consequences associated with the consumption of plant-based smoking alternatives that do not contain tobacco. These products are often marketed as a healthier option compared... Read more »
Certain plant-derived products, marketed for therapeutic or health-enhancing purposes, can pose significant risks. These products, often readily available without prescription, may contain undisclosed ingredients, interact negatively with medications, or possess inherent toxic... Read more »
